School of Medicine

The Lymphoma Research Foundation has appointed Todd Fehniger, MD, PhD, a professor of medicine at Washington University School of Medicine in St. Louis, to its scientific advisory board.

Washington University School of Medicine researchers have found that the immune system can be its own worst enemy in the fight against cancer. In a new study in mice, they found that a subset of immune cells inadvertently dampens cancer immunotherapy.

Kevin Blake, a scientific editor in the Department of Pathology & Immunology at Washington University School of Medicine in St. Louis, has been honored for an essay he wrote titled “Missing Microbiomes: Global Underrepresentation Restricts Who Research Will Benefit.”

Raja Dandamudi, MD, Vikas Dharnidharka, MD, and Tarek Alhamad, MD, all at Washington University School of Medicine in St. Louis, contributed to a large study that identified a novel way of detecting signs of organ rejection.

Andrew Chan invests in the School of Medicine to honor his mentors and help pave the way for future biomedical research leaders.

Researchers at Washington University School of Medicine in St. Louis have developed a potential drug that is effective against common bacteria that can lead to rare, dangerous illnesses.

Researchers at Washington University School of Medicine in St. Louis have developed a way to study aged neurons in the lab without a brain biopsy, allowing them to accurately model the effects of aging in the development of late-onset Alzheimer’s disease.

A nasal COVID-19 vaccine blocks transmission of the virus, according to an animal study by researchers at Washington University School of Medicine in St. Louis. The findings suggest that vaccines delivered directly to the nose or mouth could play a critical role in containing the spread of respiratory infections.

The Howard Hughes Medical Institute (HHMI) has named Washington University in St. Louis doctoral candidate Rubén A. García-Reyes and his adviser, Daniel C. Castro, to the 2024 cohort of the Gilliam Fellows Program.

A head-to-head comparison of six commercially available blood tests for Alzheimer’s disease led by researchers at Washington University School of Medicine in St. Louis reveals that two are accurate enough to replace brain scans and spinal taps in some patients with cognitive impairments.